Stanley

Stanley v. Novartis Pharmaceuticals Corp.

Good Law
11 F. Supp. 3d 987·2014 WL 1316217·2014 U.S. Dist. LEXIS 48499
United States District Court, Central District of CaliforniaApril 2, 2014Case No. CV 11-03191-JGB (OPx)California8,219 words

Opinion

Lead Opinion

Bernal, J.

ORDER

[Motions filed November 18, 2013]

Before the Court is a Motion Summary Judgment, a Motion to Exclude Testimony of Plaintiffs Case-Specific Experts, and a Motion for Daubert Evidentiary Hearing filed by Defendant Novartis Pharmaceuticals Corporation. (Doc. Nos. 55, 61, 63.) After considering the papers in support of and in opposition to the motion and arguments presented at the January 6, 2014 hearing, the Court GRANTS IN PART and DENIES IN PART Defendant’s Motion to Exclude Testimony of Plaintiffs Case-Specific Experts (Doc. No. 61), DENIES IN PART Defendant’s Motion for Daubert Evidentiary Hearing (Doc. No. 63), and GRANTS IN PART and DENIES IN PART Defendant’s Motion for Summary Judgment (Doc. No. 55).

I. PROCEDURAL HISTORY

Plaintiff Deborah Stanley (“Plaintiff’) filed a Complaint against Defendant No *993 vartis Pharmaceuticals Corporation (“Defendant” or “Novartis”) on April 14, 2011, alleging claims for strict liability, negligence — negligent manufacture, negligence — failure to warn, breach of express warranty, and breach of implied warranty. (Doc. No. 1.) On August 6, 2011, Plaintiff moved to transfer this case to the MDL court for pretrial proceedings. (Doc. No.…

Sign in to read the full opinion

Create a free account to read the complete opinion text, citation history, and good-law status for this case.